BlackRock Japan’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

BlackRock Japan’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$9K	Sell	400 -69	-15%	-$1.35K	﹤0.01%	1230
2016 Q3	$11K	Buy	469 +241	+106%	+$5.66K	﹤0.01%	1199
2016 Q2	$5K	Sell	228 -1,192	-84%	-$29.4K	﹤0.01%	1350
2016 Q1	$29K	Buy	1,420 +875	+161%	+$27.8K	﹤0.01%	1130
2015 Q4	$28K	Hold	545	–	–	﹤0.01%	1117
2015 Q3	$23K	Buy	545 +49	+10%	+$2.36K	﹤0.01%	1077
2015 Q2	$23K	Buy	496 +353	+247%	+$14.2K	﹤0.01%	1184
2015 Q1	$5K	Buy	+143	New	+$4.91K	﹤0.01%	1276
2014 Q3	–	Sell	-250	Closed	-$7K	–	1346
2014 Q2	$7K	Sell	250 -3,680	-94%	-$89.1K	﹤0.01%	1224
2014 Q1	$102K	Sell	3,930 -2,249	-36%	-$60K	﹤0.01%	1059
2013 Q4	$159K	Sell	6,179 -571	-8%	-$13.9K	﹤0.01%	949
2013 Q3	$181K	Buy	6,750 +647	+11%	+$15.4K	﹤0.01%	912
2013 Q2	$150K	Buy	+6,103	New	+$121K	﹤0.01%	918

Other funds holding PTLA

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock Japan's PTLA Position: Q4 2016 in Review

BlackRock Japan reduced its Portola Pharmaceuticals, Inc. (PTLA) stake by 15% in Q4 2016, selling an estimated $1.35K and leaving 400 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #1230.

BlackRock Japan first reported a position in PTLA in Q2 2013 and has held it in 13 quarters since. The position peaked at $181K in Q3 2013. 150 funds tracked by Wall St. Rank hold PTLA as of Q4 2016.

BlackRock Japan held 400 shares of Portola Pharmaceuticals, Inc. worth $9K as of Q4 2016.
BlackRock Japan sold 69 Portola Pharmaceuticals, Inc. shares in Q4 2016, an estimated $1.35K.
Portola Pharmaceuticals, Inc. made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1230 holding.
BlackRock Japan first reported a position in Portola Pharmaceuticals, Inc. in Q2 2013 and has held it in 13 quarters since.
BlackRock Japan's Portola Pharmaceuticals, Inc. position peaked at $181K in Q3 2013.
150 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.